This Centers of Biomedical Research Excellence (COBRE) grant, for Phase 3 Transitional Centers, aims to facilitate the full independence and long-term sustainability of existing COBRE core resources and biomedical research activities. This Notice of Funding Opportunity (NOFO) supports the transition of successful initiatives to operate autonomously, reducing reliance on initial COBRE funding. The grant enables maturation of high-impact research, allowing centers to continue vital contributions to health advancements and scientific discovery. Fostering self-sufficiency, this opportunity solidifies past achievements and secures enduring impact within the research community.
Opportunity ID: 349206
General Information
| Document Type: | Grants Notice |
| Funding Opportunity Number: | PAR-23-216 |
| Funding Opportunity Title: | Limited Competition: Centers of Biomedical Research Excellence (COBRE) (Phase 3) – Transitional Centers (P30 Clinical Trial Optional) |
| Opportunity Category: | Discretionary |
| Opportunity Category Explanation: | – |
| Funding Instrument Type: | Grant |
| Category of Funding Activity: | Health |
| Category Explanation: | – |
| Expected Number of Awards: | – |
| Assistance Listings: | 93.859 — Biomedical Research and Research Training |
| Cost Sharing or Matching Requirement: | No |
| Version: | Synopsis 1 |
| Posted Date: | Jul 11, 2023 |
| Last Updated Date: | Jul 11, 2023 |
| Original Closing Date for Applications: | Sep 30, 2025 |
| Current Closing Date for Applications: | Sep 30, 2025 |
| Archive Date: | Nov 05, 2025 |
| Estimated Total Program Funding: | – |
| Award Ceiling: | – |
| Award Floor: | – |
Eligibility
| Eligible Applicants: | Public and State controlled institutions of higher education |
| Additional Information on Eligibility: | Other Eligible Applicants include the following: Non-domestic (non-U.S.) Entities (Foreign Institutions) are not eligible to apply. Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply. Foreign components, as defined in the NIH Grants Policy Statement, are not allowed. see NOFO for eligibility details |
Additional Information
| Agency Name: | National Institutes of Health |
| Description: | The purpose of this Notice of Funding Opportunity (NOFO) is to transition the core resources and biomedical research activities of Centers of Biomedical Research Excellence (COBRE) into independence and sustainability. |
| Link to Additional Information: | https://grants.nih.gov/grants/guide/pa-files/PAR-23-216.html |
| Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
NIH Grants Information
grantsinfo@nih.gov Email:grantsinfo@nih.gov |
Version History
| Version | Modification Description | Updated Date |
|---|---|---|
Related Documents
Folder 349206 Full Announcement-PAR-23-216 -> PAR-23-216-Full-Announcement.pdf
Packages
| Agency Contact Information: | NIH Grants Information grantsinfo@nih.gov Email: grantsinfo@nih.gov |
| Who Can Apply: | Organization Applicants |
| Assistance Listing Number | Competition ID | Competition Title | Opportunity Package ID | Opening Date | Closing Date | Actions |
|---|---|---|---|---|---|---|
| FORMS-H | Use for due dates on or before January 24, 2025 | PKG00282504 | Aug 26, 2023 | Jan 24, 2025 | View | |
| FORMS-I | Use for due dates on or after January 25, 2025 | PKG00289307 | Dec 02, 2024 | Sep 30, 2025 | View |
Package 1
Mandatory forms
349206 RR_SF424_5_0-5.0.pdf
349206 PHS398_CoverPageSupplement_5_0-5.0.pdf
349206 RR_OtherProjectInfo_1_4-1.4.pdf
349206 PerformanceSite_4_0-4.0.pdf
349206 RR_KeyPersonExpanded_4_0-4.0.pdf
349206 PHS398_ResearchPlan_5_0-5.0.pdf
349206 PHSHumanSubjectsAndClinicalTrialsInfo_3_0-3.0.pdf
Optional forms
349206 PHS_Additional_IndirectCosts_2_0-2.0.pdf
349206 PHS_AssignmentRequestForm_4_0-4.0.pdf
Package 2
Mandatory forms
349206 RR_SF424_5_0-5.0.pdf
349206 PHS398_CoverPageSupplement_5_0-5.0.pdf
349206 RR_OtherProjectInfo_1_4-1.4.pdf
349206 PerformanceSite_4_0-4.0.pdf
349206 RR_KeyPersonExpanded_4_0-4.0.pdf
349206 PHS398_ResearchPlan_5_0-5.0.pdf
349206 PHSHumanSubjectsAndClinicalTrialsInfo_3_0-3.0.pdf
Optional forms
349206 PHS_Additional_IndirectCosts_2_0-2.0.pdf
349206 PHS_AssignmentRequestForm_3_0-3.0.pdf